Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Human monoclonal antibody against HLA-DR

EU orphan designation number: EU/3/05/291
Active ingredient: Human monoclonal antibody against HLA-DR
Indication: Treatment of Hodgkin’s lymphoma
Sponsor: GPC Biotech AG
Fraunhoferstraße 20, D-82152 Martinsried/Munich, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/06/2005 Centralised Orphan - Designation EMEA/OD/016/05 (2005)1879 of 16/06/2005
03/07/2008 Centralised Orphan - Removal of orphan designation from Community Register